lilly tirzepatide vial Eli to release single-dose vials of Zepbound to improve access Lilly launches vials of weight-loss

The 47-year-old started Wegovy in March 2023 and switched to Zepbound in August last year

04/05/24 Abecma (idecabtagene vicleucel) Expanded indication April 5, 2024 - Bristol Myers Squibb and 2seventy bio announced the FDA approval of Abecma (idecabtagene vicleucel), for the treatment of adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody

doi:10.1093/cvr/cvaa123 28

Bjerregaard, L

Seek urgent medical help for severe abdominal pain that may spread to the back, trouble breathing, swelling of the face or throat, fainting, or symptoms of very low blood sugar